M
Manitex Capital Inc
XTSX:MNX
Manitex Capital Inc
XTSX:MNX
Price:
0.075
CAD
Market Closed
Market Cap:
CA$9.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Manitex Capital Inc
XTSX:MNX
|
CA |
|
Splitit Ltd
ASX:SPT
|
IL |
|
Hill & Smith Holdings PLC
LSE:HILS
|
UK |
|
scPharmaceuticals Inc
NASDAQ:SCPH
|
US |
|
K
|
Ktbst Mixed Freehold and Leasehold Real Estate Investment Trust
SET:KTBSTMR
|
TH |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
AU |
|
W
|
Wal Mart de Mexico SAB de CV
SWB:4GNB
|
MX |
|
Is Finansal Kiralama AS
IST:ISFIN.E
|
TR |
|
T
|
Theon International Plc
AEX:THEON
|
CY |
|
C
|
Cemtas Celik Makina Sanayi ve Ticaret AS
IST:CEMTS.E
|
TR |
|
Damodar Industries Ltd
NSE:DAMODARIND
|
IN |
|
E
|
EP&T Global Ltd
ASX:EPX
|
AU |
|
Anterix Inc
NASDAQ:ATEX
|
US |
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
Benchmark Metals Inc
XTSX:BNCH
|
CA |
|
Ocean One Holding Ltd
HKEX:8476
|
HK |
|
H
|
Hutchison Telecommunications (Australia) Ltd
ASX:HTA
|
AU |
|
S
|
San Miguel Corp
XPHS:SMC
|
PH |
|
Servcorp Ltd
ASX:SRV
|
AU |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of MNX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MNX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
MNX Competitors Multiples
Manitex Capital Inc Competitors
Manitex Capital Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
M
|
Manitex Capital Inc
XTSX:MNX
|
9.5m CAD | 0 | -20.5 | -24.8 | -23.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.8B USD | 0.3 | 24.4 | 17.1 | 19.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.1B USD | 0.2 | 38.2 | 13.5 | 17.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.8B USD | 0.2 | 37.4 | 13.3 | 16.8 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.8B USD | 0.2 | 29.3 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.1B AUD | 2.6 | 33.1 | 24.6 | 24.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61B CNY | 0.2 | 10.8 | 14.8 | 14.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.3B USD | 0.6 | 21 | 10.3 | 14.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.4 | 15.9 | 12.2 | 12.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63B HKD | 0.1 | 7.9 | 0.6 | 0.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
